Back
United Therapeutics Stock Predictions
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
60
UTHR
United Therapeutics
Last Price:
397.46
Seasonality Move:
4.71%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!United Therapeutics Stock Forecast
- Over the next 52 weeks, United Therapeutics has on average historically risen by 25.4% based on the past 25 years of stock performance.
- United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
-
Is United Therapeutics Stock Undervalued?
The current United Therapeutics [UTHR] share price is $382.77. The Score for UTHR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, United Therapeutics has on average historically risen by 25.4% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
60
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
- United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
382.95
52-Week Low:
208.62
Prediction Charts
Market Cap:
17.09B
Price in USD:
382.77
Volume:
277.84K
Beta:
0.53
Technical Analysis
SMA50:
355.84
SMA100:
340.24
SMA200:
290.79
52-Wk Change:
70.55%
Stock Predictions
-
Is United Therapeutics stock public?
Yes, United Therapeutics is a publicly traded company. -
What is the United Therapeutics stock quote today?
The United Therapeutics stock price is 382.77 USD today. -
How to buy United Therapeutics stock online?
You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-16 | 359.59 | 369.96 | 374.73 | 359.59 |
| Oct-18 | 372.87 | 368.43 | 372.87 | 367.75 |
| Oct-21 | 366.99 | 370.60 | 372.72 | 362.32 |
| Oct-22 | 367.46 | 370.26 | 372.14 | 365.24 |
| Oct-23 | 369.49 | 352.58 | 370.26 | 342.02 |
| Oct-24 | 353.19 | 350.19 | 355.53 | 349.19 |
| Oct-25 | 351.15 | 348.65 | 352.63 | 346.66 |
| Oct-28 | 350.00 | 349.71 | 352.13 | 348.00 |
| Oct-29 | 348.48 | 352.80 | 353.30 | 347.26 |
| Oct-30 | 356.66 | 360.96 | 362.03 | 343.57 |
| Oct-31 | 362.54 | 373.94 | 375.18 | 359.71 |
| Nov-1 | 375.78 | 374.02 | 377.93 | 370.38 |
| Nov-4 | 373.98 | 376.80 | 379.51 | 371.32 |
| Nov-5 | 373.03 | 382.77 | 382.95 | 373.03 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.